In two separate conversations, Global Liver Institute Founder and CEO and industry executive and consultant hepatologist Dimitar Tonev share memories of Stephen Harrison with co-hosts Jörn Schattenberg and Roger Green.
From INCBCN 2023: Last year’s Barcelona context took a “deep dive” into NITs by exploring some early findings from the NAIL-NIT consortium.
This conversation focuses largely on system preparedness and ways to improve scanners and other screening devices. One key point: this becomes more feasible now that Rezdiffra has been approved.
SLD Think Tank 2023 co-chairs Jörn Schattenberg and Jeff Lazarus and participants Maja Thiele and Mike Betel join Louise Campbell and Roger Green to discuss high points of the recent Barcelona meting.
Panelists reflecting on Stephen Harrison share what they consider his most important and lasting professional accomplishments.
The conversation shifts to look first at challenges caused by explosion in the use of incretin agonists like GLP-1s to treat obesity and diabetes and second by the opportunities creating by on-site scanning.
Patient advocates Jeff McIntyre (Global Liver Institute) and Mike Betel (Fatty Liver Alliance, Liver Action Network) join Louise Campbell and Roger Green to discuss GLI’s premier MASH patient event, now known as Global Fatty Livery Day.
Michael Charlton describes the impact of Rezdiffra on practices and procedures in his clinic
